DFT and Molecular Docking Investigations Curcuminoid to Tribolium castaneum Telomerase Enzyme

The natural curcumin (Curcuminoid) is an anticancer compound. DFT and molecular docking curcuminoid to Tribolium castaneum telomerase were performed for curcumin (C), demethoxycurcumin (DC), and bisdemethoxycurcumin (BDC) in two structures, diketone (dk) and keto-enol (ke). Curcuminoid as inhibitor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Research journal of pharmacy and technology 2023-10, Vol.16 (10), p.4817-4824
Hauptverfasser: F. Maahury, Mirella, R. Sohilait, Mario, A. Martoprawiro, Muhamad, D. Kharisma, Viol, Listiyani, Priscilla, N. M. Ansori, Arif, L. Utami, Santika, P. Nugraha, Alexander, Rosadi, Imam, S. Mandeli, Riso, A. Ghiffari, Muhammad, T. Albari, Muhammad, R. Ghiffari, Muhammad, Zainul, Rahadian
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4824
container_issue 10
container_start_page 4817
container_title Research journal of pharmacy and technology
container_volume 16
creator F. Maahury, Mirella
R. Sohilait, Mario
A. Martoprawiro, Muhamad
D. Kharisma, Viol
Listiyani, Priscilla
N. M. Ansori, Arif
L. Utami, Santika
P. Nugraha, Alexander
Rosadi, Imam
S. Mandeli, Riso
A. Ghiffari, Muhammad
T. Albari, Muhammad
R. Ghiffari, Muhammad
Zainul, Rahadian
description The natural curcumin (Curcuminoid) is an anticancer compound. DFT and molecular docking curcuminoid to Tribolium castaneum telomerase were performed for curcumin (C), demethoxycurcumin (DC), and bisdemethoxycurcumin (BDC) in two structures, diketone (dk) and keto-enol (ke). Curcuminoid as inhibitor have optimized in gas phase used DFT/B3LYP. Optimized structure of curcuminoids conducted unplanarity for diketone and planarity for keto-enol. The HOMO-LUMO of curcuminoid spread mostly in entire molecule. Three compounds of curcuminoid could dock to active side of Tribolium castaneum telomerase. Binding energy of the diketone structure has lower energy than keto-enol structure. The binding energy of the diketone structure for the three compounds is between -7.5 to -7.7kcal/mol. This molecular docking shows intermolecular interaction between curcuminoid and active side of Tribolium castaneum telomerase dominated by hydrogen bonding. Curcuminoid diketone has potency as an inhibitor to Tribolium castaneum telomerase.
doi_str_mv 10.52711/0974-360X.2023.00781
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2909209050</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2909209050</sourcerecordid><originalsourceid>FETCH-LOGICAL-c144t-c60615b97f8f43126a543e2567efa1ef5032f6167245d1eba88f2aa3d17ad5513</originalsourceid><addsrcrecordid>eNo9kEtLAzEUhYMoWGp_ghBwPTWPyWOW0ocWKm5GcCMhnUlK6kxSkxmh_nqnrfRuzuFyOffwAXCP0ZQRgfEjKkSeUY4-pgQROkVISHwFRpf19cVjeQsmKe3QMFwykssR-JwvS6h9DV9DY6q-0RHOQ_Xl_Bau_I9JndvqzgWf4KyPVd86H1wNuwDL6DahcX0LK5067c3gStOE1kSdDFz430Nr7sCN1U0yk38dg_flopy9ZOu359XsaZ1VOM-7rOKIY7YphJU2p5hwzXJqCOPCWI2NZYgSyzEXJGc1NhstpSVa0xoLXTOG6Rg8nHP3MXz3Q2u1C330w0tFClQQVKAhYwzY-aqKIaVorNpH1-p4UBipE0x1JKWO1NQRpjrBpH-PYWd3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2909209050</pqid></control><display><type>article</type><title>DFT and Molecular Docking Investigations Curcuminoid to Tribolium castaneum Telomerase Enzyme</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>F. Maahury, Mirella ; R. Sohilait, Mario ; A. Martoprawiro, Muhamad ; D. Kharisma, Viol ; Listiyani, Priscilla ; N. M. Ansori, Arif ; L. Utami, Santika ; P. Nugraha, Alexander ; Rosadi, Imam ; S. Mandeli, Riso ; A. Ghiffari, Muhammad ; T. Albari, Muhammad ; R. Ghiffari, Muhammad ; Zainul, Rahadian</creator><creatorcontrib>F. Maahury, Mirella ; R. Sohilait, Mario ; A. Martoprawiro, Muhamad ; D. Kharisma, Viol ; Listiyani, Priscilla ; N. M. Ansori, Arif ; L. Utami, Santika ; P. Nugraha, Alexander ; Rosadi, Imam ; S. Mandeli, Riso ; A. Ghiffari, Muhammad ; T. Albari, Muhammad ; R. Ghiffari, Muhammad ; Zainul, Rahadian</creatorcontrib><description>The natural curcumin (Curcuminoid) is an anticancer compound. DFT and molecular docking curcuminoid to Tribolium castaneum telomerase were performed for curcumin (C), demethoxycurcumin (DC), and bisdemethoxycurcumin (BDC) in two structures, diketone (dk) and keto-enol (ke). Curcuminoid as inhibitor have optimized in gas phase used DFT/B3LYP. Optimized structure of curcuminoids conducted unplanarity for diketone and planarity for keto-enol. The HOMO-LUMO of curcuminoid spread mostly in entire molecule. Three compounds of curcuminoid could dock to active side of Tribolium castaneum telomerase. Binding energy of the diketone structure has lower energy than keto-enol structure. The binding energy of the diketone structure for the three compounds is between -7.5 to -7.7kcal/mol. This molecular docking shows intermolecular interaction between curcuminoid and active side of Tribolium castaneum telomerase dominated by hydrogen bonding. Curcuminoid diketone has potency as an inhibitor to Tribolium castaneum telomerase.</description><identifier>ISSN: 0974-3618</identifier><identifier>EISSN: 0974-360X</identifier><identifier>EISSN: 0974-306X</identifier><identifier>DOI: 10.52711/0974-360X.2023.00781</identifier><language>eng</language><publisher>Raipur: A&amp;V Publications</publisher><subject>Breast cancer ; Cancer therapies ; Carbon ; Dihydrofolate reductase ; Energy ; Enzymes ; Ligands ; Natural products ; Telomerase</subject><ispartof>Research journal of pharmacy and technology, 2023-10, Vol.16 (10), p.4817-4824</ispartof><rights>Copyright A&amp;V Publications Oct 2023</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c144t-c60615b97f8f43126a543e2567efa1ef5032f6167245d1eba88f2aa3d17ad5513</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>F. Maahury, Mirella</creatorcontrib><creatorcontrib>R. Sohilait, Mario</creatorcontrib><creatorcontrib>A. Martoprawiro, Muhamad</creatorcontrib><creatorcontrib>D. Kharisma, Viol</creatorcontrib><creatorcontrib>Listiyani, Priscilla</creatorcontrib><creatorcontrib>N. M. Ansori, Arif</creatorcontrib><creatorcontrib>L. Utami, Santika</creatorcontrib><creatorcontrib>P. Nugraha, Alexander</creatorcontrib><creatorcontrib>Rosadi, Imam</creatorcontrib><creatorcontrib>S. Mandeli, Riso</creatorcontrib><creatorcontrib>A. Ghiffari, Muhammad</creatorcontrib><creatorcontrib>T. Albari, Muhammad</creatorcontrib><creatorcontrib>R. Ghiffari, Muhammad</creatorcontrib><creatorcontrib>Zainul, Rahadian</creatorcontrib><title>DFT and Molecular Docking Investigations Curcuminoid to Tribolium castaneum Telomerase Enzyme</title><title>Research journal of pharmacy and technology</title><description>The natural curcumin (Curcuminoid) is an anticancer compound. DFT and molecular docking curcuminoid to Tribolium castaneum telomerase were performed for curcumin (C), demethoxycurcumin (DC), and bisdemethoxycurcumin (BDC) in two structures, diketone (dk) and keto-enol (ke). Curcuminoid as inhibitor have optimized in gas phase used DFT/B3LYP. Optimized structure of curcuminoids conducted unplanarity for diketone and planarity for keto-enol. The HOMO-LUMO of curcuminoid spread mostly in entire molecule. Three compounds of curcuminoid could dock to active side of Tribolium castaneum telomerase. Binding energy of the diketone structure has lower energy than keto-enol structure. The binding energy of the diketone structure for the three compounds is between -7.5 to -7.7kcal/mol. This molecular docking shows intermolecular interaction between curcuminoid and active side of Tribolium castaneum telomerase dominated by hydrogen bonding. Curcuminoid diketone has potency as an inhibitor to Tribolium castaneum telomerase.</description><subject>Breast cancer</subject><subject>Cancer therapies</subject><subject>Carbon</subject><subject>Dihydrofolate reductase</subject><subject>Energy</subject><subject>Enzymes</subject><subject>Ligands</subject><subject>Natural products</subject><subject>Telomerase</subject><issn>0974-3618</issn><issn>0974-360X</issn><issn>0974-306X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNo9kEtLAzEUhYMoWGp_ghBwPTWPyWOW0ocWKm5GcCMhnUlK6kxSkxmh_nqnrfRuzuFyOffwAXCP0ZQRgfEjKkSeUY4-pgQROkVISHwFRpf19cVjeQsmKe3QMFwykssR-JwvS6h9DV9DY6q-0RHOQ_Xl_Bau_I9JndvqzgWf4KyPVd86H1wNuwDL6DahcX0LK5067c3gStOE1kSdDFz430Nr7sCN1U0yk38dg_flopy9ZOu359XsaZ1VOM-7rOKIY7YphJU2p5hwzXJqCOPCWI2NZYgSyzEXJGc1NhstpSVa0xoLXTOG6Rg8nHP3MXz3Q2u1C330w0tFClQQVKAhYwzY-aqKIaVorNpH1-p4UBipE0x1JKWO1NQRpjrBpH-PYWd3</recordid><startdate>20231001</startdate><enddate>20231001</enddate><creator>F. Maahury, Mirella</creator><creator>R. Sohilait, Mario</creator><creator>A. Martoprawiro, Muhamad</creator><creator>D. Kharisma, Viol</creator><creator>Listiyani, Priscilla</creator><creator>N. M. Ansori, Arif</creator><creator>L. Utami, Santika</creator><creator>P. Nugraha, Alexander</creator><creator>Rosadi, Imam</creator><creator>S. Mandeli, Riso</creator><creator>A. Ghiffari, Muhammad</creator><creator>T. Albari, Muhammad</creator><creator>R. Ghiffari, Muhammad</creator><creator>Zainul, Rahadian</creator><general>A&amp;V Publications</general><scope>AAYXX</scope><scope>CITATION</scope><scope>04Q</scope><scope>04S</scope><scope>04W</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>20231001</creationdate><title>DFT and Molecular Docking Investigations Curcuminoid to Tribolium castaneum Telomerase Enzyme</title><author>F. Maahury, Mirella ; R. Sohilait, Mario ; A. Martoprawiro, Muhamad ; D. Kharisma, Viol ; Listiyani, Priscilla ; N. M. Ansori, Arif ; L. Utami, Santika ; P. Nugraha, Alexander ; Rosadi, Imam ; S. Mandeli, Riso ; A. Ghiffari, Muhammad ; T. Albari, Muhammad ; R. Ghiffari, Muhammad ; Zainul, Rahadian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c144t-c60615b97f8f43126a543e2567efa1ef5032f6167245d1eba88f2aa3d17ad5513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Breast cancer</topic><topic>Cancer therapies</topic><topic>Carbon</topic><topic>Dihydrofolate reductase</topic><topic>Energy</topic><topic>Enzymes</topic><topic>Ligands</topic><topic>Natural products</topic><topic>Telomerase</topic><toplevel>online_resources</toplevel><creatorcontrib>F. Maahury, Mirella</creatorcontrib><creatorcontrib>R. Sohilait, Mario</creatorcontrib><creatorcontrib>A. Martoprawiro, Muhamad</creatorcontrib><creatorcontrib>D. Kharisma, Viol</creatorcontrib><creatorcontrib>Listiyani, Priscilla</creatorcontrib><creatorcontrib>N. M. Ansori, Arif</creatorcontrib><creatorcontrib>L. Utami, Santika</creatorcontrib><creatorcontrib>P. Nugraha, Alexander</creatorcontrib><creatorcontrib>Rosadi, Imam</creatorcontrib><creatorcontrib>S. Mandeli, Riso</creatorcontrib><creatorcontrib>A. Ghiffari, Muhammad</creatorcontrib><creatorcontrib>T. Albari, Muhammad</creatorcontrib><creatorcontrib>R. Ghiffari, Muhammad</creatorcontrib><creatorcontrib>Zainul, Rahadian</creatorcontrib><collection>CrossRef</collection><collection>India Database</collection><collection>India Database: Business</collection><collection>India Database: Science &amp; Technology</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Research journal of pharmacy and technology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>F. Maahury, Mirella</au><au>R. Sohilait, Mario</au><au>A. Martoprawiro, Muhamad</au><au>D. Kharisma, Viol</au><au>Listiyani, Priscilla</au><au>N. M. Ansori, Arif</au><au>L. Utami, Santika</au><au>P. Nugraha, Alexander</au><au>Rosadi, Imam</au><au>S. Mandeli, Riso</au><au>A. Ghiffari, Muhammad</au><au>T. Albari, Muhammad</au><au>R. Ghiffari, Muhammad</au><au>Zainul, Rahadian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>DFT and Molecular Docking Investigations Curcuminoid to Tribolium castaneum Telomerase Enzyme</atitle><jtitle>Research journal of pharmacy and technology</jtitle><date>2023-10-01</date><risdate>2023</risdate><volume>16</volume><issue>10</issue><spage>4817</spage><epage>4824</epage><pages>4817-4824</pages><issn>0974-3618</issn><eissn>0974-360X</eissn><eissn>0974-306X</eissn><abstract>The natural curcumin (Curcuminoid) is an anticancer compound. DFT and molecular docking curcuminoid to Tribolium castaneum telomerase were performed for curcumin (C), demethoxycurcumin (DC), and bisdemethoxycurcumin (BDC) in two structures, diketone (dk) and keto-enol (ke). Curcuminoid as inhibitor have optimized in gas phase used DFT/B3LYP. Optimized structure of curcuminoids conducted unplanarity for diketone and planarity for keto-enol. The HOMO-LUMO of curcuminoid spread mostly in entire molecule. Three compounds of curcuminoid could dock to active side of Tribolium castaneum telomerase. Binding energy of the diketone structure has lower energy than keto-enol structure. The binding energy of the diketone structure for the three compounds is between -7.5 to -7.7kcal/mol. This molecular docking shows intermolecular interaction between curcuminoid and active side of Tribolium castaneum telomerase dominated by hydrogen bonding. Curcuminoid diketone has potency as an inhibitor to Tribolium castaneum telomerase.</abstract><cop>Raipur</cop><pub>A&amp;V Publications</pub><doi>10.52711/0974-360X.2023.00781</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0974-3618
ispartof Research journal of pharmacy and technology, 2023-10, Vol.16 (10), p.4817-4824
issn 0974-3618
0974-360X
0974-306X
language eng
recordid cdi_proquest_journals_2909209050
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Breast cancer
Cancer therapies
Carbon
Dihydrofolate reductase
Energy
Enzymes
Ligands
Natural products
Telomerase
title DFT and Molecular Docking Investigations Curcuminoid to Tribolium castaneum Telomerase Enzyme
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T06%3A36%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=DFT%20and%20Molecular%20Docking%20Investigations%20Curcuminoid%20to%20Tribolium%20castaneum%20Telomerase%20Enzyme&rft.jtitle=Research%20journal%20of%20pharmacy%20and%20technology&rft.au=F.%20Maahury,%20Mirella&rft.date=2023-10-01&rft.volume=16&rft.issue=10&rft.spage=4817&rft.epage=4824&rft.pages=4817-4824&rft.issn=0974-3618&rft.eissn=0974-360X&rft_id=info:doi/10.52711/0974-360X.2023.00781&rft_dat=%3Cproquest_cross%3E2909209050%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2909209050&rft_id=info:pmid/&rfr_iscdi=true